The website and its content are not intended to be viewed and used by French & UK healthcare professionals

Submitted by alessandra.ros… on Tue, 12/06/2022 - 09:42

Medical Reviews

Clinical applications of the results from the FOURIER open label extension study

Tags:

#Dyslipidemia #FOURIER study #LDL-C lowering therapy #Augusto Lavalle Cobo
Clinical applications of the results from the FOURIER open label extension study

As part of the REFLECTIONS - Dyslipidemia Global Newsletter #3, Prof. Lavalle Cobo (Argentina) discusses the article "Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease".

Browse the full content of the Newsletter and access the written summary of the article by clicking on the link below: